We are international
Donate
• IMF TV TEXT SIZE   

The 52nd Annual Meeting of the American Society of Hematology took place in Orlando, Florida December 4-7, 2010. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma. Please be aware that at the time of posting, in some cases, the interviewees are reporting on interim data from incomplete clinical trials. Therefore not all the data presented are final results, and it is possible that results will be different when the data has matured with long-term follow-up. None of this research has yet been peer-reviewed and published in a medical journal.

Overviews
International Overviews
Revlimid
Thalomid
Velcade
New Agents
Transplant
Relapsed/Refractory
Myeloma Stem Cells
ASH 2010 IMF Satellite Symposium
MyrooM
Others
Dr. Matsui - Origin of the Myeloma Stem Cell
William Matsui, MD
The Johns Hopkins University School of Medicine
Baltimore, Maryland
USA
Dr. Tricot - Targeting Myeloma Stem Cells through Simultaneous Inhibition of Wnt and Hedgehog (Hh) Signaling Pathways
Guido J. Tricot, MD, PhD
University of Utah School of Medicine
Salt Lake City, Utah
USA